MetaCap

Virax Biolabs Group (VRAX) Stock Chart

NASDAQ: VRAXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

0.3319-0.0491 (-12.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VRAX technical summary

The 14-day Relative Strength Index (RSI) is 12.2, below 30, the level many traders consider oversold. Over the past year, the stock ranged from $0.2928 (Nov 19, 2026) to $2.18 (Oct 7, 2026); the current price sits 2% of the way from the low to the high. Annualized 30-day volatility is 160.8%.

Based on the last session's high, low and close, the classic pivot point is $0.3434, with first resistance at $0.3581 and first support at $0.3172. These indicators describe past price behavior for Virax Biolabs Group; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
2.18 (Oct 7)
1Y low
0.2928 (Nov 19)
Last close
0.3319

VRAX price performance

1 week

-45.82%

1 month

-75.23%

VRAX price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day0.4072Price below0.4238Price below
10-day0.5297Price below0.5545Price below
20-day0.837Price below0.8086Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)0.399
Resistance 2 (R2)0.3843
Resistance 1 (R1)0.3581
Pivot point0.3434
Support 1 (S1)0.3172
Support 2 (S2)0.3025
Support 3 (S3)0.2763

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis